Search clinical trials for: AndroGel 1.62%

Total 1527 results

AbbVie

Completed

A Study of the Effect of Topical Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism

Hypogonadism

United States
VA Office of Research and Development

Recruiting

Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism

Type 2 Diabetes Mellitus | Hypogonadism

United States
Johns Hopkins University

Withdrawn

Androgen Regulation of Priapism in Sickle Cell Disease

Sickle Cell Disease | Priapism | Hypogonadism

United States
University Hospital, Clermont-Ferrand

Recruiting

Efficacy of Testosterone Gel to Restore Normal Serum Values of Testosterone During the Acute Phase of Critical Illness in Adult ICU Patients (TestICUs)

Hypermetabolism in ICU | Loss of Muscle Mass | Functional Disability After ICU | ICU Acquired Hypogonadism | Treatment With Testosterone Gel in ICU

France
Amneal Pharmaceuticals, LLC
Phase One Solutions, Inc.

Completed

Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting Conditions

Hypogonadotropic Hypogonadism | Primary Hypogonadism

United States
Repros Therapeutics Inc.

Completed

A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%

Secondary Hypogonadism

United States
Kessler Foundation
United States Department of Defense

Unknown

TRT in Combination With Electrical Stimulation and Standing: Effect on Muscle and Bone in Spinal Cord Injured Males

Spinal Cord Injury

United States
Repros Therapeutics Inc.

Completed

A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%

Secondary Hypogonadism

United States
University Hospital, Clermont-Ferrand

Recruiting

Effects of Early Testosterone Gel Administration on Physical Performance in the Critically Ill (TestICUs)

Critical Illness

France
Solvay Pharmaceuticals

Completed

Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure

Hypogonadism

United States
Abdenour Nabid
AstraZeneca

Active, not recruiting

Study on the Role of Hormonal Treatment for Two Dosage Levels of Prostate Radiation Therapy Versus Prostate Radiation Therapy Alone (PCS III)

Prostate Cancer

Canada
AbbVie

Completed

An Open-Label Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure to Testosterone Gel 1.62% Applied to the Upper Arms and Shoulders and Use of a T-shirt Barrier

Healthy
Abbott
Fovea

Completed

ESPRIT Study in Hypogonadal Men

Hypogonadism

Canada, Croatia, Germany, Kuwait, Romania, Russian Federation, Saudi Arabia, Slovenia, United Arab Emirates
Seattle Institute for Biomedical and Clinical Research

Recruiting

Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency (TEMEC)

Cancer | Fatigue | Hypogonadism, Male

United States
Suzhou Kintor Pharmaceutical Inc,

Completed

The Safety and Tolerability of GT0918 in Subjects With mHSPC and mCRPC

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) | Metastatic Castrate Resistant Prostate Cancer (mCRPC)

United States
Suzhou Kintor Pharmaceutical Inc,

Completed

Safety, Tolerability, and PK of GT0918 (Proxalutamide) in Subjects With Metastatic Castrate Prostate Cancer

Metastatic Castrate Resistant Prostate Cancer (mCRPC)

United States
University of Washington

Completed

T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone Insulin (T-IR)

Obesity | Type 2 Diabetes Mellitus | Insulin Resistance | Metabolic Disease | Androgen Deficiency

United States
Abbott

Completed

Testosterone Treatment for Hypogonadal Men

Hypogonadism
Lars Møller Pedersen
Zealand University Hospital; Copenhagen University Hospital at Herlev; Besins...

Completed

Gonadal Dysfunction in Male Long-term Survivors of Malignant Lymphoma; Vitality (Vitality)

Hypogonadism

Denmark
University of Chicago
Solvay Pharmaceuticals

Terminated

Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer

Prostate Cancer

United States
University at Buffalo
Solvay Pharmaceuticals

Completed

Effect of Androgel on Type 2 Diabetic Males With Hypogonadism

Diabetes Mellitus Type 2

United States
European Organisation for Research and Treatment...

Withdrawn

Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate Cancer (ARN-509)

Prostate Cancer
University of L'Aquila

Completed

Survival Outcomes and Tumor Molecular Profile Following Bicalutamide Neoadjuvant Therapy

Prostate Cancer

Italy
Erasmus Medical Center

Not yet recruiting

Testosterone Treatment in a Patient With 17β-hydroxysteroid Dehydrogenase Type 3 Deficiency: an N-of-1 Study (N-of-1 DSD)

Disorder of Sex Development, 46,XY

Netherlands
University at Buffalo
Solvay Pharmaceuticals

Terminated

Effect of Androgel on Atherogenesis in Type 2 Diabetic Males With Hypogonadotrophic Hypogonadism

Type 2 Diabetic Male With Hypogonadotrophic Hypogonadism

United States
Lamm, Steven, M.D.
Solvay Pharmaceuticals

Completed

Transdermal Testosterone Gel/Effect on Erection Quality as Measured by DIR

Hypogonadism

United States
Brigham and Women's Hospital
Solvay Pharmaceuticals

Completed

Testosterone Replacement in Older Men and Atherosclerosis Progression (TEAAM)

Atherosclerosis | Hypogonadism

United States
Ain Shams University

Unknown

Serum Androgen Levels as a Marker for the Severity of Preeclampsia

Severe Preeclampsia

Egypt
University of Texas at Austin

Completed

Study on the Effects of Exogenous Testosterone on Threat Perception and Behavioral Avoidance

Testosterone's Effects on Threat Perception/Response

United States
Diabetes Center of the Southwest
Solvay Pharmaceuticals

Withdrawn

Effect of Testosterone Gel Replacement on Fat Mass in Males With Low Testosterone Levels and Diabetes

Diabetes | Hypogonadism

United States
Novo Nordisk A/S

Completed

A Research Study of NNC0165-1562 and Semaglutide in People Who Are Overweight or Obese

Overweight or Obesity | Metabolism and Nutrition Disorders

United States
Icahn School of Medicine at Mount Sinai
Abbott

Completed

The Cardiac Benefit of Testosterone Replacement in Men With Low Testosterone Levels With Coronary Artery Disease After Successful Intervention of the Blockage or Narrowed Heart Artery

Coronary Artery Disease

United States
Seattle Institute for Biomedical and Clinical Research
University of Washington; VA Puget Sound Health Care System; Solvay Pharmaceuticals and other collaborators

Completed

The Effect of Testosterone on Mood and Quality of Life

Depressive Disorder | Gonadal Disorders | Hypogonadism
University Medical Center Groningen

Active, not recruiting

Short-term Testosterone Replacement in Testicular Cancer Survivors

Testicular Cancer

Netherlands
University Hospital Inselspital, Berne

Completed

Studying the Starvation Effect on Androgen Metabolism in 20 Healthy Young Women and Comparison to Women With PCOS. (SEA)

PCOS Disease

Switzerland
Medical University of South Carolina

Terminated

Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer

Prostate Cancer

United States
University of Chicago

Not yet recruiting

Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of Life

Prostate Cancer

United States
University Medical Center Groningen

Active, not recruiting

Testosterone & Tamoxifen Trial (T&T)

Male Breast Cancer

Netherlands
Marius Pharmaceuticals
Syneos Health

Completed

Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men

Hypogonadism, Male

United States
University of Roma La Sapienza

Completed

Testosterone Replacement in Metabolic Syndrome and Inflammation (TERMSINFAT)

Obesity | Metabolic Syndrome | Erectile Dysfunction | Hypogonadism

Italy
Beersheva Mental Health Center

Completed

Testosterone in Female Hypoactive Sexual Desire Disorder

Hypoactive Sexual Desire Disorder

Israel
Canisius-Wilhelmina Hospital
Besins Healthcare

Recruiting

Impact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomy (ENFORCE)

Prostatic Neoplasms | Hypogonadism | Testosterone Deficiency

Netherlands
University of California, Los Angeles
Washington University School of Medicine

Withdrawn

Testosterone for Fatigue in Men With MS

Multiple Sclerosis

United States
Memorial Sloan Kettering Cancer Center
Ferring Pharmaceuticals

Active, not recruiting

Androgen Deprivation Therapy Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate Cancer

Prostate Cancer | Prostatic Adenocarcinoma

United States
Mayo Clinic
National Institutes of Health (NIH); National Institute on Aging (NIA)

Completed

DHEA and Testosterone Replacement in Elderly

Aging | Low DHEA for Women | Low Testosterone and DHEA for Men

United States
Janssen Research & Development, LLC

Recruiting

A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPC (LIBERTAS)

Metastatic Castrate-sensitive Prostate Cancer

United States, France, Mexico, Germany, Australia, Brazil, Canada, China, Poland
Massachusetts General Hospital
Dana-Farber Cancer Institute; Brigham and Women's Hospital

Completed

Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer

Prostate Cancer

United States
Hanoi Medical University
National Hospital of Obstetrics and Gynecology

Completed

Effect of Testosterone Pretreatment in POR

Infertility

Vietnam
Cedars-Sinai Medical Center
Abbott

Withdrawn

Testosterone Therapy in Heart Failure

Heart Failure | Hypogonadism
Clarus Therapeutics, Inc.

Completed

Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men

Male Hypogonadism

United States, Germany

Search clinical trials for: AndroGel 1.62%

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahamas

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations